Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deposited polysaccharides and other biomolecular film components on contact lens surfaces represent a heterogeneous accumulation of host-derived substances from the tear film. This film primarily consists of proteins such as lysozyme, lactoferrin, and albumin, alongside various lipids like cholesterol and wax esters, and polysaccharides including mucins (Luensmann & Jones, 2012). While some components like lysozyme maintain antimicrobial activity when in their native state, the denaturation of these proteins over time can trigger inflammatory responses (Omali et al., 2015). These deposits also serve as a scaffold for bacterial attachment and biofilm formation, significantly increasing the risk of microbial keratitis and giant papillary conjunctivitis (Willcox, 2013). In the context of ophthalmic care, these biomolecules are the primary targets for removal by contact lens solutions. Cleaning agents such as surfactants, proteolytic enzymes, and oxidative systems are designed to emulsify lipids, break down protein aggregates, and disinfect the lens surface to restore biocompatibility and maintain ocular health (Lorentz & Jones, 2007).
Removal via surfactant-mediated emulsification of lipids, enzymatic proteolysis of denatured protein aggregates, oxidative degradation of organic matter, and chelation of stabilizing metal ions to disrupt the film matrix.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Contact lens deposits (Proteins, lipids, and polysaccharides).